Open Access

Expression and clinical significance of C14orf166 in esophageal squamous cell carcinoma

  • Authors:
    • Yan‑Wu Zhou
    • Rong Li
    • Chao‑Jun Duan
    • Yang Gao
    • Yuan‑Da Cheng
    • Zhi‑Wei He
    • Jun‑Xian Zeng
    • Chun‑Fang Zhang
  • View Affiliations

  • Published online on: December 16, 2016     https://doi.org/10.3892/mmr.2016.6056
  • Pages: 605-612
  • Copyright: © Zhou et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

C14orf166, a 28 kD protein regulating RNA transcription and translation, may serve a critical role in oncogenesis. The aim of the current study was to explore the association between C14orf166 expression and esophageal squamous cell carcinoma (ESCC) and to draw attention to the association between C14orf166 and the initiation, progression and prognosis of ESCC. C14orf166 expression in ESCC and paired normal tissues was detected by immunohistochemical staining, western blotting and reverse transcription‑quantitative polymerase chain reaction, and the association between C14orf166 expression and clinicopathological characters of ESCC was analyzed. Survival analysis was used to assess the prognostic significance of C14orf166 and it was observed that C14orf166 expression was higher in the ESCC tissues when compared with adjacent non‑cancerous tissues at protein (P<0.001) and mRNA levels (P<0.001). There was a significant difference in T stage, lymph node metastasis and TNM stage in patients categorized according to different C14orf166 expression levels. The overexpression of C14orf166 was associated with a shorter overall survival and disease‑free survival, and multivariate analysis indicated that C14orf166 was an independent prognostic indicator. The present study indicates that the expression of C14orf166 is elevated in ESCC, and is potentially a valuable prognostic predictor for ESCC.
View Figures
View References

Related Articles

Journal Cover

February-2017
Volume 15 Issue 2

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhou YW, Li R, Duan CJ, Gao Y, Cheng YD, He ZW, Zeng JX and Zhang CF: Expression and clinical significance of C14orf166 in esophageal squamous cell carcinoma. Mol Med Rep 15: 605-612, 2017
APA
Zhou, Y., Li, R., Duan, C., Gao, Y., Cheng, Y., He, Z. ... Zhang, C. (2017). Expression and clinical significance of C14orf166 in esophageal squamous cell carcinoma. Molecular Medicine Reports, 15, 605-612. https://doi.org/10.3892/mmr.2016.6056
MLA
Zhou, Y., Li, R., Duan, C., Gao, Y., Cheng, Y., He, Z., Zeng, J., Zhang, C."Expression and clinical significance of C14orf166 in esophageal squamous cell carcinoma". Molecular Medicine Reports 15.2 (2017): 605-612.
Chicago
Zhou, Y., Li, R., Duan, C., Gao, Y., Cheng, Y., He, Z., Zeng, J., Zhang, C."Expression and clinical significance of C14orf166 in esophageal squamous cell carcinoma". Molecular Medicine Reports 15, no. 2 (2017): 605-612. https://doi.org/10.3892/mmr.2016.6056